Crossmark

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>−</sup> subset

Crossref DOI link: https://doi.org/10.1136/jitc-2021-003385

Published Online: 2022-01-28

Published Print: 2022-01

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Veneziani, Irene https://orcid.org/0000-0002-1243-3757
Alicata, Claudia

Pelosi, Andrea https://orcid.org/0000-0003-2308-9215
Landolina, Nadine

Ricci, Biancamaria

D'Oria, Valentina

Fagotti, Anna

Scambia, Giovanni

Moretta, Lorenzo

Maggi, Enrico
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (19920)

Associazione Italiana per la Ricerca sul Cancro (21147)

Fondazione Umberto Veronesi

Ministero della Salute (RC-2020)

European Union (800924)
License Information

License valid from 2022-01-26